期刊
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY
卷 21, 期 5, 页码 426-434出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ACI.0000000000000768
关键词
anaphylaxis; hereditary alpha-tryptasemia; mast cell activation syndrome; mastocytosis; MRPGRX2; tryptase
资金
- Research Foundation Flanders/Fonds Wetenschappelijk Onderzoek [FWO: 1800614N]
Mast cell activation syndrome and anaphylaxis result from pathological degranulation of mast cells, with the importance of standardized diagnostic criteria and personalized treatment approaches being crucial. Hereditary alpha-tryptasemia may be present in these conditions.
Purpose of review Mast cell activation syndrome (MCAS) and anaphylaxis are the result of a spontaneous or triggered pathological degranulation of mast cells (MCs) and might have as substrate normal or pathological MCs (increased burden, aberrant MCs or both). Recent findings This review summarizes the most recent evidence on immunoglobulin E (IgE)-mediated and non IgE-mediated mechanisms underlying MC activation and degranulation and highlights the importance of standardized diagnostic criteria for MCAS. Application of these criteria implies that in most cases the clinical presentation of MCAS meets the diagnostic criteria for anaphylaxis. Integrating clinical parameters and diagnostic test recognition and underlying clonal MC disease are of utmost importance for a patient-tailored approach. Hereditary alpha-tryptasemia can be encountered in context of anaphylaxis, MCAS and primary MC disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据